We have been running clinical trials on agentic AI for two years.
Most of the industry is still evaluating it. We build and operate AI-native infrastructure for clinical trials, market entry, and physician-led innovation.
in clinical research and market entry
building the physician network
certified
represented
operating agentic clinical AI
per CAIM session
Clinical trials
Trial delivery with deep roots in decentralized designs and digital health technologies, rebuilt on agentic AI.
Learn more →U.S. market entry
A 90-day program taking international life-science companies from foreign entity to U.S. operating presence.
Learn more →Physician innovation
Seven years, more than 100 certified clinician-innovators, 13 or more countries.
Learn more →Trials are not slow because people are slow.
They are slow because the work is serialized. A protocol becomes a CRF, which becomes a dataset, which becomes a specification, which becomes a table, and every one of those transitions is a handoff where someone waits, someone reconciles, and someone re-does what was already done upstream.
Agentic systems collapse the serialization. Not by working faster at each step, but by removing the queue between steps and putting review at every stage instead of at the end.
We saw this early because we were operating the tools, not writing about them.
We do not build every layer. We assemble the ones that work.
We operate as the integration layer across a global ecosystem of AI partnerships spanning clinical trials, diagnostics, biosurveillance, and market infrastructure. Each partner is chosen for a specific capability and vetted the same way: we run it on live work before we put a client on it.